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Abstract
Background: DNA methylation is an epigenetic mechanism central to development and maintenance of complex
mammalian tissues, but our understanding of its role in intestinal development is limited.
Results: We use whole genome bisulfite sequencing, and find that differentiation of mouse colonic intestinal stem
cells to intestinal epithelium is not associated with major changes in DNA methylation. However, we detect
extensive dynamic epigenetic changes in intestinal stem cells and their progeny during the suckling period,
suggesting postnatal epigenetic development in this stem cell population. We find that postnatal DNA methylation
increases at 3′ CpG islands (CGIs) correlate with transcriptional activation of glycosylation genes responsible for
intestinal maturation. To directly test whether 3′ CGI methylation regulates transcription, we conditionally disrupted
two major DNA methyltransferases, Dnmt1 or Dnmt3a, in fetal and adult intestine. Deficiency of Dnmt1 causes
severe intestinal abnormalities in neonates and disrupts crypt homeostasis in adults, whereas Dnmt3a loss was
compatible with intestinal development. These studies reveal that 3′ CGI methylation is functionally involved in the
regulation of transcriptional activation in vivo, and that Dnmt1 is a critical regulator of postnatal epigenetic changes
in intestinal stem cells. Finally, we show that postnatal 3′ CGI methylation and associated gene activation in
intestinal epithelial cells are significantly altered by germ-free conditions.
Conclusions: Our results demonstrate that the suckling period is critical for epigenetic development of intestinal
stem cells, with potential important implications for lifelong gut health, and that the gut microbiome guides and/or
facilitates these postnatal epigenetic processes.
Background
The ontogeny of mammalian intestinal development en-
compasses three distinct phases: morphogenesis and cy-
todifferentiation during late gestation, the shift from
intra- to extra-uterine environment at birth, and the
transition from an exclusively milk diet rich in fat to a
solid diet rich in carbohydrates at weaning. To meet the
increased environmental and nutritional demands after
birth, early postnatal life is a critical period during which
the proliferative units of the intestinal epithelium known
as crypts of Lieberkühn undergo extensive structural
and functional maturation [1]. The intricate morphology,
cellular composition and turnover rate of intestinal
crypts are all controlled by multipotent intestinal stem
cells (ISCs) located at the base of flask-shaped mucosal
invaginations [2]. ISCs therefore constitute the ‘control
center’ that regulates lifelong intestinal health and dis-
ease. Remarkably, however, while it has long been known
that postnatal intestinal development is characterized by
rapid growth and changes in brush border digestive
functions [3], our understanding of postnatal develop-
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Recent technological developments enable the identifi-
cation and isolation of live ISCs with high purity. Lgr5+
cells from mouse intestinal crypts were functionally vali-
dated as bona fide ISCs by lineage tracing studies [4].
With the sophistication of genetic studies that allow
gene ablation in Lgr5+ ISCs, we are developing a broader
appreciation of signaling pathways and transcriptional
factors that control their early cell fate decisions [5]. Al-
though the role of epigenetics in intestinal development
has gained more attention recently [6–10], we still know
little about the fundamental epigenetic mechanisms that
control the origin, identity, and behavior of ISCs during
development.
DNA methylation of cytosine in CpG dinucleotides is
a well-established epigenetic mechanism critical for mam-
malian development. CpG density is extensively depleted
in the mammalian genome; however, about 1 % of the
genome escaped this CpG depletion, resulting in scattered
regions of high CpG density termed CpG islands (CGIs).
Interestingly, whereas most CpGs in the genome are
methylated, significantly less methylation is observed at
CGIs. CGI methylation appears to target specific regions
such as promoters of X-linked genes on the inactive X
chromosome in females, genomically imprinted loci, and
genes associated with tissue-specific expression [11,
12]. Although DNA methylation is widely viewed as
an epigenetic mark for gene silencing, we recently
discovered that methylation at non-promoter CGIs,
particularly at the 3′ end of genes, promotes human
gene activation through a CTCF-dependent enhancer-
blocking mechanism [13], underscoring the need for
unbiased methods to study epigenetic regulation by
DNA methylation during development.
The ontogenic periods, when developmentally pro-
grammed DNA methylation is being established, are
vulnerable to environmental influences [14]. DNA
methylation requires enzymes, DNA methyltransfer-
ases (DNMTs), and nutrition-dependent metabolic
pathways that supply methyl groups [15–17]. It has
become clear that postnatal establishment of gut
microbiota plays a key role in several aspects of intes-
tinal physiology, including morphological features
[18, 19], altered glycosylation patterns [20–22], and
stem cell activity [23–26]. Further, the intestinal
microbiota has the capacity to produce folate and a
variety of vitamins (i.e., B12 and B6) affecting host
one-carbon metabolism [27, 28]. This is important be-
cause mammals are incapable of synthesizing folate
and other B vitamins (which act as methyl donors
and cofactors in biological methylation reactions) so
they have to be obtained exogenously from diet and
intestinal bacteria. Until now, little is known about the im-
pact of gut microbiome on the host epigenome. In adult in-
testinal epithelial cells, methylation of the Toll-like receptor
gene TLR4 depends on intestinal commensal bacteria [29,
30], and DNA methylation in blood is associated with
microbiota composition during pregnancy [31]. No previ-
ous studies, however, have examined how the early postna-
tal microbiome affects developmental epigenetics in host
ISCs.
Here, employing genome-wide approaches, we show
that ISCs undergo dynamic postnatal epigenetic changes
during the suckling period. Using genetic approaches
that permit conditional and inducible inactivation of
Dnmts, we provide evidence that Dnmt1 regulates post-
natal epigenetic mechanisms, with a major impact on
ISC function in both neonatal and adult intestine. Fi-
nally, we demonstrate that the postnatal gut microbiome
is required to guide and/or enable these postnatal epi-
genetic processes.
Results
The DNA methylome changes more during postnatal ISC
maturation than during differentiation of ISCs
We focused mainly on ISCs from the colon since this re-
gion of the gut is the primary site of several human dis-
eases, including inflammatory bowel disease and cancer.
Although Lgr5+ cells are known to exhibit stem cell
properties before birth and drive the dynamics of devel-
oping crypts in the small intestine [32], their ontogeny has
not been examined in the developing colon. We,
therefore, characterized the temporal emergence of
Lgr5+ colonic ISCs by fluorescence activated cell sort-
ing (FACS) at embryonic and fetal stages using
knock-in Lgr5-EGFP-CreER mice [4]. Lgr5-EGFP+ co-
lonic ISCs are detectable at embryonic day 14.5
(E14.5) and become an appreciable subpopulation by
E18.5 (Additional file 1: Figure S1).
To determine whether the ISC population undergoes
epigenetic changes during early postnatal life, we per-
formed unbiased DNA methylation mapping by whole-
genome bisulfite sequencing (WGBS) [33] in Lgr5-EGFP
+ colonic ISCs at birth [postnatal day 0 (P0)] and at the
end of the suckling period (P21). Since colonic ISCs are
continually undergoing differentiation to replace the
short-lived population of differentiated epithelial cells, we
analyzed the DNA methylomes of sorted epithelial cell ad-
hesion molecule (EpCAM)-positive and Lgr5-enhanced
green fluorescent protein (EGFP)-negative population (the
descendants of ISCs) [34–36] to identify DNA methyla-
tion changes that correlate with differentiation (differenti-
ated cells versus ISCs). We found that at both ages, global
methylation levels were significantly lower in differenti-
ated cells relative to ISCs (P < 0.0001; Additional file 1:
Figure S2). Across the 25 million CpG sites analyzed,
average CpG methylation levels were 73.9 % and 70.3 %
at P0, and 73.1 % and 70.0 % at P21, for ISCs and differ-
entiated cells, respectively. We compared specific
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genomic regions that underwent methylation changes
either during maturation from P0 to P21 [maturation-
associated differentially methylated regions (mDMRs)]
or during differentiation from ISCs to epithelial cells
[differentiation-associated differentially methylated re-
gions (dDMRs)]. Our analysis revealed that there are
more mDMRs than dDMRs, particularly at CGI-
associated genomic regions (Fig. 1a). Interestingly, at
non-CGIs, mDMRs frequently lose methylation, but at
CGIs, mDMRs predominantly gain methylation (Fig. 1a).
There was no significant enrichments of a gene region
for non-CGI associated DMRs as compared to known
genes, regardless of mDMR or dDMR, methylation
gains or losses (Fig. 1b). The pattern was com-
pletely different, however, at CGI-associated mDMRs;
methylation gains at CGI mDMRs were strongly as-
sociated with the gene body (introns and exons, ex-
cluding the first and last exons) and 3′ end of genes
(last exon and 3′ UTR) (Fig. 1b). Together, these re-
sults demonstrate that changes in genomic DNA
methylation patterns are more dynamic during post-
natal ISC maturation than during differentiation of
ISCs to epithelial cells.
3′ CGI-associated mDMRs are functionally implicated in
development and intestinal maturation
To evaluate the functional significance of mDMRs, we
performed DAVID Gene Ontology (GO) analyses to
identify statistically overrepresented biological processes
(see Additional file 2: Tables S1 and S2 for lists of CGI
and non-CGI mDMR genes). This analysis revealed mul-
tiple developmental processes significantly associated
with mDMR genes showing methylation gains at non-
promoter CGIs (Additional file 2: Table S3 contains a list
of all significantly enriched GO terms). For example,
genes with mDMRs in the gene body or 3′ CGI are
enriched for embryonic organ development, intracellular
signaling cascade, regulation of transcription, and cell
morphogenesis involved in differentiation (Additional
file 1: Figure S3). Of particular interest is the glycosphin-
golipid biosynthetic process, which is intimately linked
to intestinal maturation by modulating mucus barrier
function; glycosphingolipids may additionally modulate
receptors for toxins, virus, and bacteria [37, 38]. Indeed,
a careful examination of the gene list revealed a cluster
of 3′ CGI genes responsible for glycan biosynthesis,
including glycosidase (Net37), glycosyltransferases
(A3galt2, B4galnt1, B4galnt4, and Gal3st1) and other
related enzymes (Fkrp and Phospho1). When we com-
pared the gene lists for 3′ CGI-associated mDMRs in
ISCs and their differentiated progeny during the suck-
ling period, we found, as expected, that most (60 %)
of the mDMR genes in differentiated cells are found
in ISCs (Additional file 1: Figure S4a). Since
differentiated cells are more exposed to the intestinal
lumen than are the ISCs in the crypts, mDMRs
unique to differentiated cells may reflect responses to
the very different luminal environment at P21 relative
to P0. Not surprisingly, only 7 % (41/517) of mDMR
genes in the differentiated cells overlap with P21
dDMR genes.
Methylation gains at 3′ CGIs of glycosylation genes
correlate tightly with transcriptional activation in the
developing ISCs
To gain insight into the function of the methylation
changes at mDMRs, we used RNA-Seq to comprehensively
examine the relationship between ISC mDMRs and gene
expression. We found that 3′ CGI methylation was posi-
tively correlated with gene expression (Additional file 1:
Figure S4b), suggesting that postnatal establishment of
DNA methylation in ISCs plays a functional role in intes-
tinal maturation. To validate our genome-wide results, we
focused on ten candidate genes, including five with
mDMRs at non-CGIs and five with mDMRs at CGIs. All
the non-CGI mDMR genes (Rnf43, Zbtb22, Fam109a,
Adamtsl5, and Mif) showed DNA methylation loss in the
ISCs during the suckling period. They were selected be-
cause their mDMRs are proximal to CGIs, in regions
known as CGI shores, which have been shown to exhibit
tissue-specific methylation correlated with gene expres-
sion [39]. Notably, Rnf43 is a stem cell E3 ligase which
acts as a negative regulator of Wnt signaling [40]. All the
CGI mDMR genes (B4galnt1, Net37, Lpar5, Fkrp, and
Phospho1) showed gain of methylation during ISC devel-
opment. Among them, four (B4galnt1, Net37, Fkrp, and
Phospho1) encode enzymes that affect glycosylation, and
one (Lpar5) is involved in sodium and water absorption in
the intestine [41].
To assess the correlation between DNA methylation
and gene expression over an extended time-series, we
analyzed DNA methylation and gene expression quanti-
tatively in both ISCs and differentiated epithelial cells at
E18.5, P0, P21, P100 (young adult), and P300 (old adult).
In all cases, the results (Fig. 2) not only confirmed our
WGBS findings but also demonstrated that ISC epigen-
etic regulation extends beyond the suckling period.
Interestingly, we found no significant correlation be-
tween methylation changes at non-CGI genes and gene
expression during the suckling period, but over the ex-
tended time course, expression increases lagged behind
methylation decreases (Fig. 2a; Additional file 2: Table
S4). Conversely, at all five of the 3′ CGI genes examined
we found a positive temporal correlation between 3′
CGI methylation and transcriptional activation across
development (Fig. 2b; Additional file 2: Table S4). To
study at higher resolution the developmental dynamics
of DNA methylation in these regions, we performed
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methylation analysis of 3′ CGI genes at P4, P7, P11, P16,
and P18. The 3′ CGI methylation increases for several
glycosylation genes (B4galnt1, Net37, and Fkrp) were
most dramatic during the first week of postnatal life
(Additional file 1: Figure S5), suggesting that some de-
velopmental signal coincident with parturition drives
Fig. 1 Unbiased analysis of DNA methylomes in colonic ISCs and their progeny during the suckling period. a Numbers of DMRs identified from
the comparisons between either developmental stages (mDMRs, left) or differentiation states (dDMRs, right). Analyses were based on the
association of DMRs with non-CGIs (top), and with CGIs (bottom). Black bars indicate methylation gains and white bars indicate methylation losses.
b Distribution of mDMRs or dDMRs relative to gene region categories based on RefSeq annotation of all known genes. CGI-associated mDMRs
are enriched in the gene body and 3′ end
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these changes. Most importantly, the nearly identical
DNA methylation dynamics in ISCs and differentiated
epithelial cells, from fetal to adult life (Fig. 2a, b), further
support the conclusion from our genome-wide analyses
that differentiation of ISCs does not entail widespread
changes in DNA methylation.
DNMT1-mediated DNA methylation is essential for
postnatal intestinal development
To further address the functional role of DNA methylation
in intestinal development, we performed genetic studies by
targeting genes responsible for the establishment and
maintenance of DNA methylation. Dnmt3a and Dnmt3b
are known as de novo methyltransferases (to establish
methylation patterns during development) and Dnmt1 is
considered a maintenance methyltransferase (to propagate
established methylation patterns in daughter cells during
mitosis) [42]. By examining the mRNA expression patterns
of these three Dnmts from P0 to P300, we found that
Dnmt3b expression is essentially undetectable in either
ISCs or differentiated epithelial cells (Fig. 3a, green lines).
Dnmt3a expression is intermediate and relatively constant
(Fig. 3a, red lines), whereas Dnmt1 expression is the stron-
gest in both ISCs and differentiated epithelial cells and
Fig. 2 Temporal analysis of both DNA methylation and gene expression at identified candidate genes. a Non-CGI mDMR genes undergoing
developmental loss of methylation. b 3′ CGI mDMR genes undergoing developmental gain of methylation. The suckling period is highlighted in
gray. For each gene, exon–intron structure (including isoforms) and CpG map are shown on the top. Thin blue bars represent the 5′ or 3′ UTRs
and thick blue boxes represent coding exons. Each vertical line represents a CpG site and green bars indicate CGIs. Red dotted boxes indicate the
regions analyzed for CpG methylation. The gene expression is relative to β-actin. Error bars represent standard error of the mean of three to five
biological replicates
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Fig. 3 (See legend on next page.)
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increases progressively with age (Fig. 3a, blue lines). Based
on these results, we focused our functional analyses on
Dnmt3a and Dnmt1. We derived Dnmt3af/f; Villin-Cre
and Dnmt1f/f; Villin-Cre mouse lines to ablate individual
Dnmt genes in an intestinal epithelial cell-specific fashion.
In both Dnmt3a and Dnmt1 homozygous mutant mice,
we detected a nearly 90 % reduction in Dnmt3a and
Dnmt1 expression in neonatal intestines, respectively
(Fig. 3b; Additional file 1: Figure S6). At P0, Dnmt3a and
Dnmt1 homozygous mutant pups were indistinguishable
from their control littermates in terms of body weight and
gross appearance. By P7, however, Dnmt1 homozygous
mutant mice showed significantly reduced body weight
and shortened intestinal length compared with their litter-
mate controls (Fig. 3c). Most (~80 %) of Dnmt1 homozy-
gous mutant mice died around the time of weaning (P21).
Survivors had crypts containing cells that had escaped
Dnmt1 deletion. In contrast to the Dnmt1 mutants, no ob-
vious changes were detected in Dnmt3a homozygous mu-
tant mice (Additional file 1: Figure S7). To better
characterize the postnatal lethal phenotype of Dnmt1 mu-
tants, we performed histological and immunohistochemi-
cal analyses. These demonstrated that at P7, loss of Dnmt1
results in morphological changes characterized by villus-
atrophy and vacuolated cells in both small intestine
(Additional file 1: Figure S8) and colon (Fig. 3d). In
addition, the Dnmt1 mutant colons showed fewer goblet
cells (indicated by Alcian blue staining), and a decrease in
Ki-67+ proliferative cells (Fig. 3d). These alterations were
not apparent at P0 or P3 (Additional file 1: Figure S9), indi-
cating that the observed epithelial deterioration occurs
postnatally. Notably, signs of severe mucosal damage, in-
cluding epithelial pseudostratification and adenoma-like le-
sions, were occasionally observed in P7–P21 Dnmt1
homozygous mutant mice (scored by pathologist; Add-
itional file 1: Figure S8b). These histopathological changes
potentially indicate indirect consequences of epithelial in-
jury or inflammation.
To investigate the direct impact of Dnmt loss on postnatal
epigenetic regulation of gene expression, we focused on the
five previously characterized 3′ CGI mDMRs, and per-
formed quantitative analyses of DNA methylation and gene
expression in colonic epithelial cells at P7. Dnmt3a deletion
caused significant methylation decreases for B4galnt1, Net37,
and Lpar5 (Fig. 3e; Additional file 1: Figure S10), but
these were only modestly associated with expression
(Fig. 3f ). Dnmt1 deletion, however, resulted in greater
methylation decreases in four of the five genes
(Fig. 3e; Additional file 1: Figure S10), causing stron-
ger changes in expression (Fig. 3e). In all cases, loss
of methylation was correlated with reduced expres-
sion, consistent with the notion that 3′ CGI methyla-
tion acts as a transcriptional activator. For Net37, the
degree of expressional reduction far exceeded the al-
teration of methylation, reflecting broader impact of
Dnmt1 loss on additional regulatory regions, consist-
ent with previous observations [7, 9]. Together, these
results suggest a regulatory function of 3′ CGI
methylation in postnatal mouse intestinal develop-
ment, providing the first in vivo evidence to support
the involvement of Dnmt1 in controlling postnatal
epigenetic regulation and epithelial maturation.
Dnmt1-mediated DNA methylation is required for the
control of adult ISC homeostasis
The data above on pan-intestinal epithelial cell deletion
(by Villin-Cre) raised an intriguing possibility that
Dnmt1-mediated postnatal epigenetic mechanisms could
be involved in the regulation of adult ISC function. To
test this, we derived a Dnmt1f/f; Lgr5-EGFP-CreER
mouse line, in which deletion of Dnmt1 can be induced
in adult ISCs by tamoxifen (referred to hereafter as
Dnmt1ISCKO). We used two types of controls: the Dnmt-
wild type; Lgr5-EGFP-CreER mice with the same tamoxi-
fen treatment, and the Dnmt1f/f; Lgr5-EGFP-CreER mice
without tamoxifen treatment. Based on real-time RT-
PCR analysis of Dnmt1 expression in Lgr5-EGFP+ cells,
we estimated that tamoxifen treatment induces around
80 % ablation of Dnmt1 in both small intestine and
colon (Fig. 4a). Using confocal immunofluorescent ana-
lyses for Dnmt1 and EGFP, we analyzed Dnmt1 protein
expression in Lgr5+ crypt-based columnar (CBC) cells.
Tamoxifen-injected wild-type control mice strongly
expressed Dnmt1 in the Lgr5-EGFP+ CBCs (white ar-
rowheads, top panel in Fig. 4b). Expression of Dnmt1
was also detected in villus epithelial cells, consistent with
our previous real-time RT-PCR results (Fig. 3a). In small
intestines of Dnmt1ISCKO mice, co-staining of EGFP and
(See figure on previous page.)
Fig. 3 Deletion of Dnmt3a or Dnmt1 in developing intestine. a mRNA expression analysis of three Dnmts in Lgr5+ ISCs and differentiated
epithelial cells at various postnatal ages. b mRNA expression analysis confirms efficient epithelial cell specific ablation of Dnmt3a (left, by 90 %) or
Dnmt1 (right, by 95 %) in homozygous mutant mice. c Villin-Cre mediated Dnmt1 deletion caused significant reductions in body weight (left) and
intestinal length (right) at P7. d Immuno-histochemical staining for Dnmt1, Alcian blue and Ki-67 showed blunted villi, reduced goblet cells, and
decreased proliferative cells in the colons of Dnmt1f/f; Villin-Cre mice. Scale bars, 100 μm. DNA methylation (e) and gene expression (f) analysis of
3′ CGI-associated genes in the colonic intestinal epithelium collected from Dnmt3a and Dnmt1 homozygous mutant mice at P7, compared with
control littermates. Error bars represent standard error of the mean of at least three replicate
experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 versus control (two-sided t test)
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Dnmt1 showed decreased Dnmt1 expression in Lgr5-
EGFP+ ISCs (solid line marks the mutant crypt, Fig. 4b).
It is known that Cre recombinase is expressed mosai-
cally in the intestinal epithelium of Lgr5-EGFP-CreER
mice [4]. Indeed, in the same Dnmt1ISCKO mice, some
Lgr5-EGFP-negative crypts, which are Dnmt1 wild type
as a result of no recombination, retained strong Dnmt1
staining (dotted line circles the wild-type crypt with
white arrowheads pointing to the Dnmt1+ cells, Fig. 4b,
bottom panel). Similar mosaic deletion patterns were ob-
served in colons of Dnmt1ISCKO mice (solid circles indicate
mutant crypts, and dashed circles indicate wild-type
crypts with arrowheads pointing to Dnmt1+ cells, Fig. 4c).
Therefore, our RT-PCR and immunostaining results for
Lgr5+ cells suggest efficient but incomplete ablation of
Dnmt1 from the adult ISCs. Notably, compared with the
well-defined triangle shapes of wild-type CBCs (arrow-
heads in Fig. 4b), mutant CBCs in Dnmt1ISCKO mouse
Fig. 4 Deletion of Dnmt1 in adult ISCs alters crypt homeostasis and postnatal epigenetic regulation. a mRNA expression analysis confirms
decreased expression of Dnmt1 in Lgr5-EGFP+ ISCs isolated from Dnmt1ISCKO mice, in both small intestine (SI) and colon. TAM tamoxifen, WT wild
type. b Immunofluorescent analysis of ISCs (EGFP, green), Dnmt1 (red), and nuclei (Topro-3, blue) in small intestine crypts. In tamoxifen-treated
control (Dnmt-wild type; Lgr5-EGFP-CreER) mice (top panel), dotted lines mark crypts, and ISCs (green) show strong Dnmt1 staining (indicated by
white arrowheads). In Dnmt1ISCKO mice (bottom panel), the Lgr5-EGFP+ mutant crypt (outlined by solid line) shows decreased Dnmt1 staining and
aggregation of CBCs, whereas an adjacent EGFP-negative crypt (outlined by dashed line) contains CBCs with wild-type Dnmt1 and high expression
of Dnmt1 (white arrowheads). Scale bars, 20 μm. c Immunofluorescent analysis of ISCs and Dnmt1 in control (top panel) and Dnmt1ISCKO (bottom
panel) colons. Similar mosaic patterns of Dnmt1 deletion are observed in colon. Scale bars, 20 μm. d Immunofluorescent analysis of Paneth cells
in Dnmt3aISCKO and Dnmt1ISCKO mice. Paneth cells staining positive for lysozyme (red) are exclusively located at crypt bottoms in Dnmt3aISCKO mice
(top panel), whereas lysozyme+ cells (arrowheads) were detected at villus epithelia in Dnmt1ISCKO mice (bottom panel). Scale bars, 50 μm. Far right
panels show a magnified view of Lgr5-EGFP+ ISCs for each genotype; the clear segregation between CBCs and Paneth cells is lost in the Dnmt1ISCKO
mice. DNA methylation (e) and gene expression (f) analysis of 3′ CGI-associated genes in the colonic Lgr5+ ISCs collected from wild-type (wt) control,
Dnmt3af/f; Lgr5-EGFP-CreER and Dnmt1f/f; Lgr5-EGFP-CreER mice, with or without tamoxifen (TAM) administration. Error bars represent standard error of
the mean of at least three replicate experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 versus control (two-sided t test)
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crypts showed altered morphologies with most cells ag-
gregating into clumps (solid circles, Fig. 4b; Additional
file 1: Figure S11), suggesting dysregulated crypt homeo-
stasis. Our observations on Paneth cells also supported
this notion. In small intestines of Dnmt1ISCKO mice,
Lysozyme+ Paneth cells lost their clear compartmental-
ization with ISCs, and some were mislocalized in the villus
epithelium (arrowheads, bottom panel in Fig. 4d). Normally,
Paneth cells are localized in the crypt (top panel in
Fig. 4d).
In parallel, we derived a Dnmt3af/f; Lgr5-EGFP-CreER
mouse line and applied the same strategy to evaluate the
functional consequences of induced Dnmt3a deletion in
adult ISCs (Dnmt3aISCKO). After tamoxifen administra-
tion, we confirmed the high-efficiency of gene ablation in
Lgr5-EGFP+ ISCs from Dnmt3aISCKO animals (Additional
file 1: Figure S12a). In contrast to Dnmt1ISCKO,
Dnmt3aISCKO small intestine and colon exhibited no ob-
vious morphological abnormalities (Additional file 1:
Figure S12b). Lysozyme staining revealed normal
Paneth cell localization (top panel in Fig. 4d). Overall,
these results were consistent with our observation in
the Dnmt3af/f; Villin-cre mice.
Finally, to determine whether dysregulation of postna-
tal epigenetic mechanisms might be involved in the ob-
served phenotypic defects of Dnmt1-deficient ISCs, we
analyzed DNA methylation and gene expression of three
genes (B4galnt1, Net37, and Lpar5) that normally
undergo increases in DNA methylation at 3′ CGIs. All
three exhibited significantly reduced DNA methylation
in the ISCs after disruption of Dnmt1 but not Dnmt3a
(Fig. 4e; Figure S13). As in the Villin-Cre experiments
(Fig. 3e, f ), hypomethylation at the 3′ CGIs led to re-
duced mRNA expression (Fig. 4f ). These results provide
further evidence that Dnmt1 is a prominent player in
control of the postnatally programmed DNA methyla-
tion in ISCs, while Dnmt3a is somewhat dispensable.
Collectively, these data indicate that Dnmt1-mediated
developmentally programmed epigenetic mechanisms
are involved in the regulation of adult ISC function.
Microbial exposure guides developmental epigenetics in
the colonic epithelium
Our discovery of postnatal epigenetic regulation in the
ISC population highlights a potential critical ontogenic
window in which the infant microbiome could influence
intestinal development. To test this, we profiled DNA
methylation in genetically identical C57 wild-type mice
under either conventional (CNV) or germ-free (GF) con-
ditions. We collected the colons at E15.5, P0, P21, and
P100, and used the unfractionated tissues for methyla-
tion analysis. We quantitatively measured DNA methyla-
tion of over 90 CpG sites spanning 15 genes identified
by WGBS as showing postnatal methylation changes in
ISCs. In addition, to rule out the possibility that micro-
biome effects on DNA methylation were simply due to
the changes of global methylation, we analyzed the
methylation of two generic repetitive elements (Line1
and IAP). Remarkably, in CNV mice, an unsupervised
hierarchical clustering based purely on DNA methyla-
tion yielded a perfect correspondence with stage of
development (Fig. 5a). In GF mice, however, these devel-
opmental changes in DNA methylation were markedly
dysregulated, at both P21 and P100 (Fig. 5b). The most
pronounced effect was in a large block of regions nor-
mally targeted for methylation increases from P0 to P21;
in GF mice many of these changes did not occur, even
by P100 (Fig. 5b, indicated by purple boxes). Addition-
ally, we found similar methylation profiles of newborn
mice (P0) in both CNV and GF conditions, consistent
with these epigenetic changes being induced by
colonization. It is worth mentioning that the macronu-
trient composition of the GF mouse diets was similar
to that of the control CNV mouse diet (Additional
file 2: Table S5). Further, we observed essentially the
same results for GF mice housed at different facilities.
Interestingly, we found significantly increased mRNA
levels of Dnmt1 in the GF mice at P21 and P100
(Additional file 1: Figure S14), indicating that the
methylation defects under the GF condition are not
due to insufficient Dnmt1 activity.
To test whether the effects of the microbiome on
DNA methylation might be mediated by altered cellu-
lar composition, and also to evaluate effects on gene
expression, we obtained another cohort of mice at
weaning under either CNV (N = 5) or GF (N = 5) con-
ditions. Rather than studying whole colon, we isolated
intestinal epithelial cells and assessed DNA methyla-
tion and expression of five 3′ CGI-associated genes.
In agreement with our previous results, the GF condi-
tion significantly reduced the developmentally pro-
grammed methylation at all genes analyzed (Fig. 6a).
We observed significantly reduced gene expression for
the two genes with the greatest methylation decre-
ments in GF mice (B4galnt1 and Phospho1; Fig. 6b).
Thus, the alterations in developmental epigenetics we
observed in the whole colon of GF mice (Fig. 5b)
occur within colonic epithelial cells.
Finally, to address the direct link between postna-
tal DNA methylation and the gut microbiome, we
performed fecal microbiota transplant (FMT) experi-
ments to conventionalize the GF mice at age P25.
Based on our previous results, we examined 3′ CGI
methylation of B4galnt1 and Phospho1 in colonic
epithelial cells at P100 under FMT (N = 3) compared
with GF (N = 3) and CNV (N = 2) conditions. As
shown in Additional file 1: Figure S15, reestablishing
commensal microbiota significantly increases DNA
Yu et al. Genome Biology  (2015) 16:211 Page 9 of 16
methylation at multiple CpG sites of 3′ CGIs. Con-
sistently, restored DNA methylation at the 3′ CGI of
the Phospho1 gene in FMT mice leads to signifi-
cantly increased gene expression.
Discussion
Compared with the rapid recent progress in epigenome
studies of embryonic and other somatic stem cells, epi-
genetic mechanisms in ISCs remain understudied. Re-
cently, two genome-wide DNA methylation studies
examined the role of DNA methylation in adult ISCs
during differentiation, but yielded inconsistent results [7,
9]. Whereas one study showed limited DNA methylation
dynamics during ISC differentiation [7], the second iden-
tified substantially more DMR regions, albeit with low
levels of change [9]. Here, to address whether DNA
methylation plays a regulatory role in ISC function, we
chose to take a different approach, using an unbiased
method to compare DNA methylomes in purified ISCs
and their descendants at two distinct developmental
stages (birth and weaning). Most notably, we found only
minor methylation changes during differentiation of
ISCs to epithelial cells, and that specific fractions of the
genome undergo dynamic DNA methylation changes —
apparent postnatal epigenetic regulation — within the
ISC populations during the suckling period (i.e., from P0
to P21). Interestingly, a detailed characterization of these
changes revealed continuous changes throughout intes-
tinal maturation and into adulthood, supporting our
earlier observations that postnatal epigenetic regulation
proceeds well beyond infancy [43]. Thus, our results
provide a framework for testing the role of DNA
Fig. 5 The germ-free condition affects developmentally programmed CGI methylation. a Unsupervised hierarchical clustering analysis on the basis
of DNA methylation profiling in mouse colon under conventional (CNV) conditions. Each row indicates a CpG site and the corresponding gene
name is indicated on the right. Each column indicates a sample analyzed and the corresponding age is indicated on the bottom. Methylation
levels range from unmethylated (blue) to fully methylated (red), as indicated by the color legend at the bottom of the graphs. b DNA methylation
profiling in mouse colon under germ-free (GF) conditions. The orders for CpG sites and age groups are pre-defined based on the conventional
samples. Purple boxes highlight 3′ CGI-associated CpGs at which the methylation levels are significantly altered by germ-free conditions
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methylation ontogeny in the origin, identity, and behav-
ior of ISCs across the developmental continuum.
Our results showed tight positive correlation of 3′
CGI methylation and gene expression throughout de-
velopment. This (Fig. 2b) corroborates our previous
reports that 3′ CGI methylation acts as a transcrip-
tional activator during human embryonic stem cell
differentiation [13], and is positively correlated with
expression during murine hypothalamic development
[44]. This is also consistent with our studies of con-
ditional inactivation of Dnmt1, in which erasure of
3′ CGI methylation in ISCs resulted in decreased
gene expression in vivo (Figs. 3 and 4). Mechanistic-
ally, it has been proposed that 3′ CGI methylation
controls gene activation through a CTCF-dependent
enhancer-blocking mechanism [13]. Although beyond
the scope of this study, future studies will be
necessary to reveal the exact mechanistic roles of
epigenetic regulators, including CTCF, in the devel-
opmentally programmed transcriptional regulation of
ISCs.
Conditional deletion of Dnmts in the intestine
allowed us to dissect intrinsic mechanisms required
for setting and maintaining developmentally pro-
grammed 3′ CGI methylation. Single knockout of
Dnmt3a in intestinal epithelial cells caused significant
decreases of 3′ CGI methylation, suggesting that
Dnmt3a is involved in de novo methylation during
early intestinal development. These reductions, how-
ever, were relatively modest and resulted in only
slight transcriptional changes in associated genes, in-
dicating that other de novo Dnmt genes might com-
pensate for the loss of Dnmt3a. On the other hand,
deletion of Dnmt1 strongly decreased 3′ CGI methy-
lation levels and led to concomitant decreases in
transcription. Somewhat unexpectedly, when we in-
duced Dnmt3a deletion by Lgr5-Cre in adolescent
ISCs (when methylation gains at 3′ CGIs were still
underway) we found no effects on de novo methyla-
tion. In contrast, after adolescent depletion of Dnmt1,
we detected significantly reduced DNA methylation
levels and mRNA expression in the ISCs. Taken to-
gether, our results indicate that Dnmt1, in addition to
its dogmatic role as a maintenance methylase, also
exhibits de novo methylation activity, as suggested by
previous studies [45, 46].
Our studies demonstrated that the phenotypic conse-
quences of intestine-specific Dnmt1 deletion depend on
the developmental stage at which the perturbation oc-
curs. Compared with the effects of Dnmt1 loss later in
life, Dnmt1 deletion during early postnatal life produced
more striking morphological and functional changes, in-
cluding severe postnatal growth retardation and develop-
ment of adenomatous lesions in the intestine. Consistent
Fig. 6 The germ-free condition affects developmentally programmed
3′ CGI methylation and transcription in intestinal epithelial cells. a DNA
methylation status at multiple CpG sites of five 3′ CGI-associated
genes are compared between two conditions: CNV (N = 5, red)
and GF (N = 5, green). The error bars represent standard error of
the mean. The error bars for the GF group are not showing as they are
smaller than the symbols. b Gene expression analysis of corresponding
3′ CGI genes. *P < 0.05, **P < 0.01 and ***P < 0.001, N.S. not significant
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with our findings, the recent study by Sheaffer et al. [9]
showed that conditional disruption of Dnmt1 by Villin-
Cre in the adult intestine caused only modest changes in
intestinal crypt homeostasis. To understand the contri-
bution of DNA methylation to the observed defects in
Dnmt1 mutants, the previous study focused on identify-
ing differential methylation during the transition from
ISCs to differentiated epithelial cells [9]. Although our
genome-wide analysis identified methylation changes in
the differentiation axis similar to the previous report, we
found substantially more profound methylation changes
in the ISCs themselves during maturation from P0 to
P21. Interestingly, a genome-wide study of other epigen-
etic marks also observed nearly identical histone marks
(H3K4me2 and H3K27ac) and DNase I hypersensitivity
in the adult ISCs and their progeny [8]. In light of these
results, we suggest that the control of adult ISC function
throughout life may be influenced by derangement of
these postnatal maturational epigenetic processes. It re-
mains to be determined, however, to what extent develop-
mentally programmed epigenetic mechanisms contribute
to the phenotypic defects seen in the Dnmt1 mutant mice.
Future studies with genome-wide analysis of Dnmt1 and/
or Dnmt3a mutants in both neonatal and adult ISCs
should resolve this question.
Our discovery of coordinated developmental changes
in 3′ CGI methylation and expression of genes encoding
glycosylation enzymes highlights the potential patho-
physiological relevance of developmental epigenetics in
adult ISCs. Glycosphingolipids and membrane glycopro-
teins decorate the interior structures and outer surfaces
of all living cells and, together with the secreted mucins,
contribute to the glycocalyx of the intestinal epithelial
surface. It has been postulated that the control mecha-
nisms by which developmental changes in enterocyte
surface glycosylation patterns are regulated may have a
direct impact on host and age susceptibility to patho-
genic bacterial infection, inflammatory bowel disease,
and cancer metastasis [47, 48]. In support of this conjec-
ture, our findings of postnatal epigenetic development at
B4galnt1, which encodes beta 1,4-N-acetylgalactosami-
nyltransferase 1 and normally undergoes transcriptional
activation by DNA methylation at 3′ CGIs, are of par-
ticular interest. B4galnt1 regulates postnatal develop-
ment of colonic epithelial cells through the biosynthetic
pathway of Sda blood group antigen [49], and is impli-
cated in inflammatory bowel disease, colorectal and
other types of cancer [50, 51].
Lastly, our studies suggested an epigenetic paradigm
for a symbiotic relationship between the host and com-
mensal microbes in the intestine. Studies in germ-free
mice revealed that the intestinal microflora profoundly
impacts intestinal physiology and mucosal immune
functions. For example, germ-free mice are deficient in
mucosal surface area and exhibit reduced crypt renewal
rate [23, 52]. In vivo studies demonstrated that the resi-
dent bacteria have a glycosylation-modulating effect on
the intestinal cell surface [20, 53]. By comparing germ-
free and conventional mice, we found that the develop-
mental establishment of intestinal DNA methylation pat-
terns, particularly at the 3′ CGIs of glycosylation genes,
was substantially blunted in the absence of gut microbiota.
Further, this was not due to impaired Dnmt1 activity.
Given that the gut microbiome synthesizes critical cofac-
tors required for one carbon metabolism [27, 28], it could
be proposed that the methylation deficits result from a
general lack of these metabolites. The overall maintenance
of DNA methylation at generic repeats (Line1 and IAP in
Fig. 5), however, suggested that, rather than simply facili-
tating methylation, the microbiome played a more sophis-
ticated instructive role. Moreover, our observations in
fecal transplant mice supported the direct link between
methylation and the microbiome, and indicated that dif-
ferent genomic regions could have different responsive-
ness to microbiota at distinct developmental stages (i.e.,
pre-weaning versus after-weaning). Clearly, future studies
will be needed to determine how microbial–host metabol-
ite interactions contribute to the epigenetic effects — for
example, by supplementing GF mice with dietary folate
and/or folate-producing bacterial strains. Given the
profound effects of the gut microbiome in human
health and disease, it will be important to determine
whether specific bacterial species are involved and
whether there is a critical developmental period for
the microbiota to influence ISC developmental epi-
genetics. If so, this may open the possibility for devel-
opmentally targeted probiotic therapies to provide
lifelong protection against intestinal disease.
Conclusions
We have shown that ISCs undergo important postnatal
epigenetic development. Our report sheds light on en-
dogenous and exogenous signals that guide the DNA
methylation machinery to orchestrate intestinal epige-
nomic development, with potential important implica-
tions for lifelong gut health.
Materials and methods
Experimental animals
The mouse lines have been described previously: Lgr5-
EGFP-CreER (also known as Lgr5EGFP-IRES-CreERT2) mice
(backcrossed to a pure C57BL/6 J background) express-
ing EGFP and Cre recombinase under the control of the
endogenous Lgr5 regulatory sequences [4], Villin-Cre
(Tg(Vil-cre)997Gum) mice (on the C57BL/6 J back-
ground) expressing Cre recombinase under the control
of mouse Villin1 promoter [54], Dnmt3af/f (also known
as Dnmt3a2lox/2lox) mice carrying floxed exon 19 [55–57],
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and Dnmt1f/f (also known as Dnmt12lox/2lox) mice carry
carrying floxed exons 4–5 [56, 58] (both are in a pure 129
background). Germ-free mice (C57BL/6 J) were main-
tained in three independent gnotobiotic animal facilities at
Medical University of South Carolina, Brigham and
Women’s Hospital and Baylor College of Medicine. PCR
genotyping assays, including primer sequences and PCR
conditions, are summarized in Additional file 2: Table S6.
All animal research was carried out in accordance with
the NIH Guide for Care and Use of Laboratory Animals
and approved by the Baylor College of Medicine Animal
Care and Use Committee (Protocol AN-6775).
Tamoxifen treatment
To induce ISC-specific knockout, adult Dnmt3af/f; Lgr5-
EGFP-CreER or Dnmt1f/f; Lgr5-EGFP-CreER mice were
intraperitoneally injected every other day with tamoxifen
(1 mg in corn oil × three times). We examined the small
intestines and colons 7 and 14 days after initial tamoxi-
fen injection.
Isolation of Lgr5+ ISCs and differentiated epithelial cells
EGFP-labeled Lgr5+ ISCs (Lgr5-EGFP+) and EpCAM-
labeled epithelial cells (Lgr5-EGFP-/EpCAM+) were iso-
lated based on a previously published method [13]. For
genome-wide studies, mice were pooled to obtain suffi-
cient amounts of ISCs (500 ng genomic DNA). We
crossed Lgr5-EGFP-CreER mice with wild-type C57 mice,
pooled 16 litters to obtain P0 samples, and 7 Lgr5-EGFP+
offspring to obtain P21 samples. For candidate gene stud-
ies, all animals were individually analyzed, except that for
the embryonic and P0 time-points, mice were pooled from
one litter and used as one biological sample. Flow cyto-
metric analysis and cell sorting were performed using
EGFP and anti-EpCAM antibody (Biolegend) on a four-
way MoFlo cell sorter (Beckman-Coulter).
Whole-genome DNA methylation profiling by
bisulfite-sequencing
WGBS was performed and analyzed according to a previ-
ously published protocol [33]. Briefly, sonicated, adaptor-
ligated genomic DNA was treated with sodium bisulfite by
the EZ DNA Methylation-Direct kit (Zymo Research).
The bisulfite-modified DNA was amplified (18 cycles)
using adaptor-specific primers and fragments of 200–
500 bp were isolated. The quantity and size distribution of
libraries were determined using the Pico Green fluores-
cence assay and the Agilent 2100 Bioanalyzer, respectively.
Each library was sequenced as 100-bp paired-end reads
with planned sequencing depth of ~1 billion reads and
20× coverage per sample (Additional file 2: Table S7). The
standard Illumina pipeline was used to perform base call-
ing. After removing adaptor sequences and low-quality
tails, reads were mapped to the mouse reference genome
(mm9) by Bismark [59]. All the Bisulfite-Seq data have
been uploaded to the Gene Expression Omnibus (GEO)
with accession number [GEO:GSE58532].
Whole-genome transcriptional profiling by RNA-Seq
RNA-Seq libraries were prepared as described previously
[60] and sequenced on the Illumina HiSeq 2000 instru-
ment with planned sequencing depth of 60 million reads
per sample. We used BOWTIE2 software [61], which
uses the Burrows-Wheeler transform for efficient re-
alignment of RNA sequences. Cufflinks [62] was used
for counting functions, quality control summaries, and
fragments per kilobase per million reads (FPKM). All
RNA-Seq data have been uploaded to GEO with acces-
sion number [GEO:GSE64054].
Quantitative DNA methylation analysis by
bisulfite-pyrosequencing
Methylation at specific CpG sites was quantified by
bisulfite-pyrosequencing using the PyroMark Q96 MD
instrument [63]. Primer sequences and sequencing as-
says are summarized in Additional file 2: Table S8. For
each assay, set-up included positive controls (SssI-treated
genomic DNA) and negative controls (whole genome
amplified genomic DNA), mixing experiments to rule
out bias, and repeated experiments to assess reproducibil-
ity. Annealing temperatures were optimized to overcome
PCR bias as previously reported [64].
Quantitative gene expression analysis by real-time
RT-PCR
TaqMan gene expression assays (Applied Biosystems)
were used to quantify mRNA of target genes. Assays
were designed to have primers/probes to span exon–
exon junctions (Additional file 2: Table S9). All experi-
ments were carried out in triplicate and relative gene ex-
pression was calculated by the ratio of the target genes




For histological analyses, mouse intestines were fixed in
4 % paraformaldehyde. Fixed tissues were paraffin-
embedded, sectioned, and stained with haematoxylin and
eosin according to standard laboratory protocols at the Cel-
lular and Molecular Morphology Core at the Texas Medical
Center Digestive Diseases Center. Procedures for immuno-
histochemistry and confocal immunofluorescent analyses
have been described [65]. The primary antibodies were
anti-DNMT1 (sc-20701, Santa Cruz for immunohisto-
chemistry and ab87654, Abcam for immunofluorescence),
GFP (ab6673, Abcam) and lysozyme (AR024-5R, Biogenex).
5′-Ethynyl-2′-deoxyuridine (EdU) staining was performed
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using the Click-iT® EdU Alexa Fluor® 555 imaging kit
(Invitrogen) according to the manufacturer’s instructions.
Alcian blue staining
Slides were de-waxed, rehydrated to water, and incu-
bated in Alcian Blue solution (0.01 g/ml Alcian blue in
3 % acetic acid, pH 2.5) for 30 minutes. The slides were
then washed briefly in water and mounted using Cyto-
seal 60 (Richard-Allan Scientific).
Bioinformatic analysis
Our main analyses of WGBS focus on all 200-bp ‘bins’
in the genome at approximately nucleosomal resolution
as previously described [33]. For bins containing at least
two CpG sites and covered by at least ten reads, we cal-
culated the methylation level as the percentage of all
methylated CpG site counts within each bin. For gene
category annotation, we used RefSeq downloaded from
the UCSC genome database. For CGI annotation, a list
of 23,021 mouse CGIs was identified based on a previ-
ous report [66]. The methylation level for a gene or CGI
category was computed as the mean of methylation
levels of associated bins.
The enrichment of GO annotation terms was analyzed
using the DAVID Functional Annotation Tool [67]. We
identified gene associated mDMRs with methylation
changes greater than 15 %, and divided them into eight
groups: (1) methylation gain at 5′ CGI (N = 316); (2)
methylation gain at gene body or 3′ CGI (N = 583); (3)
methylation loss at 5′ CGI (N = 239); (4) methylation
loss at gene body or 3′ CGI (N = 348); (5) methylation
gain at 5′ non-CGI (N = 323); (6) methylation gain at
gene body or 3′ non-CGI (N = 900); (7) methylation loss
at 5′ non-CGI (N = 513); (8) methylation loss at gene
body or 3′ non-CGI (N = 1710).
FMT experiments
At age P25, the GF mice were orally inoculated with
freshly prepared fecal slurries from at least two CNV
donor mice, and subsequently housed in the conventional
animal facility. For DNA methylation and gene expression
analysis, we isolated colonic epithelial cells from three
groups of mice at P100 under either GF (N = 3), FMT
(N = 3), or CNV (N = 2) conditions. All mice were
housed in the animal facilities at Baylor College of
Medicine.
Statistical analysis
Statistical significance of global methylation differences
was determined based on a test for proportions with the
200-bp bin as the unit of observation. Statistical signifi-
cance of the overlap with each GO category was deter-
mined by Fisher’s exact test and the P values were adjusted
by Bonferroni correction to control false discovery rate
(FDR). For the comparisons of candidate genes, quantita-
tive DNA methylation and expression results are expressed
as mean ± standard error of the mean. For both DNA
methylation and gene expression data, we confirmed the
normality of data by Kolmogorov-Smirnov test. Student’s t
tests with two-tailed distribution were used to determine
the significance of difference. P < 0.05 was considered
statistically significant. Age -adjusted regression analysis
was performed to assess the statistical correlation be-
tween DNA methylation and gene expression. To ac-
count for multiple testing, we controlled FDR and
reported FDR-adjusted P values using the Benjaimini-
Hochberg procedure.
Additional files
Additional file 1: Supplemental Figures S1–S15. (PDF 2922 kb)
Additional file 2: Supplemental Tables S1–S9. (PDF 2694 kb)
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